CVS Health (CVS) Q3 2026 Earnings Review: higher outlook meets a planned business split
Earnings results
- EPS beat
Actual: $2.09 adjusted profit per share · Cons.: $1.65
- Revenue beat
Actual: $108.399B · Cons.: about $104.69B
- Guidance raised
2026 adjusted profit per share: at least $8.20 vs. $7.90–$8.10.
What the company reported
CVS beat earnings and revenue estimates, raised its full-year profit and cash-flow outlook, and separately proposed separating the retail pharmacy business from insurance and health services.
Q3 2026 earnings recap
CVS Health raised its profit outlook and proposed a retail pharmacy separation, giving investors both a stronger earnings recovery and a major restructuring to assess.
- Q3 adjusted profit per share reached $2.09 versus $1.65 expected, while revenue rose 5.4% to $108.4 billion and beat the roughly $104.69 billion forecast.
- Aetna’s medical benefit ratio, the share of premiums spent on care, improved to 91.3% from 92.8%, helping insurance adjusted operating profit rise to $912 million from $314 million.
- CVS raised its 2026 adjusted profit target to at least $8.2 per share and operating cash-flow target to at least $15.5 billion, improving its capacity to invest and manage debt.
- The proposed first-half 2028 split would put retail pharmacies in CVS Pharmacy while Aetna, Caremark and care-delivery businesses remain together, subject to approvals and tax conditions.
- The November 3 closing price represented about 10.6 times trailing reported profit, but the eventual allocation of debt and costs will shape the value of each separate business.
- Shares traded about 3.7% below the previous close before open on November 4, falling beneath the prior 20-day and 50-day moving averages despite the earnings beat.
Watch medical-cost trends and the planned companies’ debt, dividend and operating arrangements, because higher care spending or separation costs could erode the earnings recovery.
Financials, technicals and earnings
Charts through Nov 3, 2026.
Technical setup and risks
Improving insurance margins support earnings, while the proposed 2028 separation introduces questions about each business’s debt, dividends, costs and ability to grow independently.
AI-assisted earnings research with verified issuer results. Charts use the stated completed session. Educational information; investing involves risk.